Annual conference returns to Washington, D.C., Sept. 15-16; addresses challenges in establishing a new paradigm for how evidence of efficacy and safety is generated.Continue reading
Category Archives: AZBio News
AZBio Member Spotlight – Prickly Pear Health
Based in Arizona, Prickly Pear Health is building technology to uncover one of the most overlooked gaps in healthcare: the connection between women’s hormonal health and brain health.Continue reading
Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies
— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures —
— Advancing second-generation Emperor TAH development toward a fully implantable system —
Continue reading
AZBio Member Spotlight – Navi Nurses
Based in Arizona, Navi Nurses is redefining what personalized nursing care looks like outside of the hospital, ensuring that no patient or family has to navigate complex medical situations alone.Continue reading
NIH SBIR and STTR Parent Notices of Funding Opportunity (NOFOs) have officially been released
These programs provide non-dilutive funding to help small businesses advance innovative technologies and bring promising discoveries closer to commercialization. Whether you’re developing a new therapeutic, diagnostic, medical device, digital health solution, or research tool, NIH funding can help accelerate your path forward.Continue reading
Banner Health report shows Arizona research driving national medical innovation
Milestones in Research details 1,300 clinical and translational research studies, FDA-approved heart device, landmark Alzheimer’s prevention work
AZBio Member Spotlight – Gut-Brain Axis Therapeutics
Gut-Brain Axis Therapeutics is developing microbiota transplant therapy for treating gut-brain disorders in autism and related conditions. The company’s founding is deeply personal. Dr. James Adams, who leads the organization, has a daughter with autism, which motivated him 25 years ago to focus his research on treatments for the condition. 15 years ago, he led a study which demonstrated that gastrointestinal symptoms strongly correlated with autism symptoms, and that children with autism were missing beneficial bacteria and had harmful yeast. That led to their first clinical trial of microbiota transplant, which was very successful and led to 5 more, with the last 2 funded by Gut-Brain Axis Therapeutics.Continue reading
Honoring Their Sacrifice – Memorial Day 2026
Memorial Day is a time to remember and honor the men and women who gave their lives in military service to our country. Some died in war time, others died in peacetime. Some died in foreign lands, others died right here at home. We also remember service members who through their injuries, exposure to toxins, or wartime experiences had lives that ended too soon even though they made it home alive. Their sacrifice is the highest price that can be paid for the opportunities we have as Americans. Today, we remember them, honor them, and most if all, should be thankful for the lives that they lived and the sacrifice that they made for us.Continue reading
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)
Chronic HDV is considered the most severe form of viral hepatitis due to rapid disease progression towards liver failure and liver-related death –
– Approval introduces the first FDA-approved therapy for this disease with limited treatment options and high unmet need
Continue reading
Second Annual Research Week Celebrates Innovation and Collaboration
For the second straight year, the University of Arizona College of Medicine – Phoenix hosted Research Week. The series of events, bridged between two weeks, served as a fantastic showcase for how the college and its partners are driving discovery and fueling the future of healthier Arizona.Continue reading